BAL PHARMA
|
The Current P/E Ratio of BAL PHARMA is 22.88.
Share Price | ₹105.7 | Apr 28,2025 |
Market Cap | ₹168.1 Cr | |
Earnings-TTM | ₹7.3 Cr | TTM-Consolidated Results |
Price/Earnings | 22.88x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of BAL PHARMA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹168.1 Cr] as on Apr 28,2025
(/) Earnings [ ₹7.3 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 22.88x ]
Thus, for BAL PHARMA , the investors are currently willing to pay 22.88 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of BAL PHARMA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of BAL PHARMA over the last five years.
Historical PE (Price/Earnings) ratio chart of BAL PHARMA
PE Ratio Performance Analysis for BAL PHARMA
- BAL PHARMA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 21.13x.
- BAL PHARMA 's operated at median p/e ratio of 19.51x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BAL PHARMA 's p/e ratio peaked in Mar2023 at 40.83x.
- BAL PHARMA 's p/e ratio hit its five-year low in Mar2020 of 0x.
How does BAL PHARMA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
BAL PHARMA | 7.35 | 22.88 | 168.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 38.47 | 441,910.0 |
DIVIS LABORATORIES LTD | 2,067.00 | 77.42 | 160,035.0 |
CIPLA LTD | 5,000.43 | 25.11 | 125,540.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 60.63 | 112,894.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 18.44 | 100,110.0 |
MANKIND PHARMA LTD | 2,050.73 | 51.49 | 105,587.0 |
ZYDUS LIFESCIENCES LTD | 4,591.80 | 19.41 | 89,137.2 |
LUPIN LTD | 2,892.10 | 33.28 | 96,241.1 |
AUROBINDO PHARMA LTD | 3,500.25 | 20.69 | 72,411.4 |
ABBOTT INDIA LTD | 1,334.46 | 47.37 | 63,214.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs BAL PHARMA 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.44x |
Max industry PE | 77.42x |
Median industry PE | 33.28x |
Average industry PE | 37.74x |
You may also like the below Video Courses